Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)

Trial Profile

Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)

Completed
Phase of Trial: Phase III

Latest Information Update: 13 May 2016

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary)
  • Indications Gastric cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ACTS-GC
  • Sponsors Taiho Pharmaceutical
  • Most Recent Events

    • 27 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Oct 2010 According to a Taiho Pharmaceutical media release, the five-year follow-up results of this trial were presented at the meeting of the European Society for Medical Oncology (ESMO-2010).
    • 15 Oct 2010 According to a Taiho Pharmaceutical media release, these results are expected to be reported at the 48th Annual Meeting of the Japan Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top